Quality of interaction database management systems;Calidad estructural de las bases de datos de interacciones

Farmacia Hospitalaria

Volumn 33, Issue 3, 2009, Pages 134-146

  Rodriguez Terol A ^a   Caraballo, M O ^b   Palma, D ^b   Santos Ramos, B ^c   Molina, T ^a   Desongles, T ^c   Aguilar, A ^a  

^a Servicio Andaluz de Salud   (Spain)

^b Servicio de Farmacia de Atencin Primaria   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Bases de datos; Database management systems; Drug interaction; Evaluaci n de calidad; Interacciones medicamentosas; Quality assurance

Indexed keywords

ARTICLE; DATA BASE; DRUG COST; DRUG INFORMATION; DRUG INTERACTION DATABASE; INFORMATION RETRIEVAL; LANGUAGE; MEDLINE; QUALITY CONTROL;

EID: 67650729962     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(09)71155-9     Document Type: Editorial

References (82)

1. J.U. Rosholm, L. Bjerrum, J. Hallas, J. Worm, and L.F. Gram Polypharmacy and the risk of drug-drug interactions among Danish elderly Danish Medical Bulletin 45 1998 210 213
2. Estudio APEAS: estudio sobre la seguridad de los pacientes en Atención Primaria de Salud. Madrid: Ministerio de Sanidad y Consumo; 2008.
3. J.M. Recalde, M.V. Zunzunegui, and F. Beland Interacciones de fármacos prescritos en población mayor de 65 años Aten Primaria 22 1998 434 439
4. R.J. Michocki, P.P. Lamy, F.J. Hooper, and J.P. Richardson Drug prescribing for the elderly Arch Farm Med 2 1993 441 444
5. National Prescribing Service. What is polypharmacy? NPS News n.° 13.2000.
6. National Health Service. Medicines for older people. 2001. Department of Health [citado 18 May 2007]. Disponible en: http://www.gov.uk/nsf/olderpeople. htm
7. A. Calvet, M. Díez de Ulzurrun, M.T. Pérez, and J. Esteras Interacciones farmacológicas en tratamientos crónicos: medidas correctoras para su prevención en un área básica de salud rural Aten Primaria 27 2001 33 37 (Pubitemid 32148074)
8. T. Bermejo Viñedo, and C. Pérez Menendez Conde Aplicación de las nuevas tecnologías a la farmacia hospitalaria en España Farm Hosp 31 2007 17 22
9. V.L. Minh, G.M. McCart, and C. Tsourounis An assessment of Free, online Drug-Drug Interaction Screening Programs (DSPs) Hospital Pharmacy 38 2003 662 668 (Pubitemid 36828823)
10. J. Abarca, D.C. Malone, E.P. Armstrong, A.J. Grizzle, P.D. Hansten, and R.C. Van Bergen Concordance of severity ratings provided in four drug interaction compendia J Am Pharm Assoc (Wash) 44 2004 136 141
11. Consejo General de Colegios Oficiales de Farmacéuticos. Base de Datos del Conocimiento farmacéutico BOT PLUS [citado 17 May 2007]. Disponible en: www.portalfarma.com
12. XiZ Comunicacion. Medinteract [citado 10 May 2007]. Disponible en: www.medinteract.net
13. Sociedad Española de Farmacia Hospitalaria. Guía de la SEFH [citado 26 May 2007]. Disponible en: www.sefh.es
14. Lexi comp. Lexi-interact [citado 18 May 2007]. Disponible en: www.lexi.com
15. Medscape, Drug Interaction Checker [citado 19 May 2007]. Disponible en: www.medscape.com
16. P.D. Hansten, and J.R. Horn Drug Interactions Analysis and Management 2007 Facts and Comparisons St. Louis
17. Thomson Healthcare. Drug-reax [citado 20 May 2007]. Disponible en: www.micromedex.com
18. I.H. Stockley Interacciones Farmacológicas 2. ed. 2006 Pharma Editores Barcelona
19. D.S. Tatro Drug Interaction Facts 2007 Facts and Comparisons San Carlos
20. K.A. Clauson, M.J. Seamon, A.S. Clauson, and T.B. Van Evaluation of drug information databases for personal digital assistans Am J Health-Syst Pharm 61 2004 1015 1023
21. L. Galatti, G. Mazzaglia, A. Greco, E. Sessa, C. Cricelli, and G.C. Schito Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice Pharmacoepidemiol Drug Saf 16 2007 422 428 (Pubitemid 46656864)
22. N.L. Katende-Kyenda, M.S. Lubbe, J.H. Serfontein, and I. Truter Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa Journal of the Medical Association of South Africa 98 2008 109 113 (Pubitemid 351356315)
23. W.M. Sweileh, A.F. Sawalha, and N.A. Jaradat Extent of potential drug interactions among patients receiving anti-hypertensive medications Saudi Medical Journal 26 2005 548 552 (Pubitemid 40711435)
24. Grupo Ars XXI. Martindale [citado 15 May 2007]. Disponible en: www.imedicinas.com
25. J. Peral Aguirregoitia, U. Lertxundi Etxebarria, M.J. Martínez Bengoechea, O. Mora Atorrasagasti, E. Franco Lamela, and I. Gabilondo Zelaia Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicación informática Farm Hosp 31 2007 99 100
26. P. Amariles, N.A. Giraldo, and M.J. Faus Interacciones medicamentosas: aproximación para establecer y evaluar su relevancia Med Clin (Barc) 129 2007 27 35 (Pubitemid 47413829)
27. A. Rodríguez Terol, B. Santos Ramos, M.O. Caraballo Camacho, and M. Ollero Baturone Relevancia clínica de las interacciones medicamentosas Med Clin (Barc) 130 2008 758 759
28. Agencia Española del Medicamento. AGEMED [citado 25 May 2007]. Disponible en: www.egemed.es
29. American Society of Health-system pharmacy. American Hospital formulary Service Drug Information [citado 23 May 2007]. Disponible en: www.asph.org
30. Drugdigest. Check Interaction [citado 23 May 2007]. Disponible en: www.drugdigest.org
31. Drugmaster group. Druint software [citado 23 May 2007]. Disponible en: www.drugmastersl.com
32. Drugs.com. Drug Interaction Checker [citado 23 May 2007]. Disponible en: www.drugs.com
33. Epocrates [citado 20 May 2007]. Disponible en: www.epocrates.com
34. Coordinadores de la Agencia española del medicamento y Productos Sanitarios. Guía de Prescripción Terapéutica [citado 23 May 2007]. Disponible en: www.imedicinas.com/GTPage/
35. MedicinNet [citado 27 May 2007]. Disponible en: www.medicinenet.com
36. Servicio Biblioteca Nacional de Medicina [citado 25 May 2007]. Disponible en: www.medlineplus.gov
37. Dr. Koop [citado 24 May 2007]. Disponible en: www.drkoop.com
38. RxList.inc. [citado 23 May 2007]. Disponible en: www.fdb.rxlist.com
39. Grupo Ars XXI. Stockley Alertas; 2007.
40. The medical letter, inc. Adverse drug interaction program [citado 22 May 2007]. Disponible en: www.medicaletter.com
41. Agence Franaise de Sécurité Sanitarie des Produits de Santé. Thesaurus des interactions Medicamenteus [citado 23 May 2007]. Disponible en: www.agemed.sante.gouv.fr
42. Drug Bank [citado 2 Jun 2007]. Disponible en: www.drugbank.ca
43. D.S. Wishart, C. Knox, A.C. Guo, S. Shrivastava, M. Hassanali, and P. Sto thard DrugBank: a comprehensive resource for in silico drug discovery and exploration Nucleic Acids Res 34 2006 D668 D672
44. Drug Interaction Knowledge-base (DIKB) [citado 24 May 2007]. Disponible en: www.ieeexplore.ieee.org
45. R.D. Boyce, C. Collins, J. Horn, and I. Kalet Modeling drug mechanism knowledge using evidence and truth maintenance IEEE Trans Inf Technol Biomed 11 2007 386 397 (Pubitemid 47098763)
46. Drug Interaction Ontology [citado 28 May 2007]. Disponible en: www.bio.cs.titech.ac.jp
47. S. Yoshikawa, K. Satou, and A. Konagaya Drug interaction ontology (DIO) for inferences of possible drug-drug interactions Medinfo 11 2004 454 458
48. FDA MedWatch database. Department of food and Human Services [citado 26 May 2007]. Disponible en: www.fda.gov
49. N.L. Katende-Kyenda, M.S. Lubbe, J.H. Serfontein, and I. Truter Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa Journal of the Medical Association of South Africa. 98 2008 109 113 (Pubitemid 351356315)
50. General Practice Research Database (GPRD) [citado 7 Jun 2007]. Disponible en: www.gprd.com
51. T.A. Hammad, D.J. Graham, J.A. Staffa, C.J. Kornegay, and G.J. Dal Pan Onset of acute myocardial infarction after use of non-steroidal antiinflammatory drugs Pharmacoepidemiol Drug Saf 17 2008 315 321 (Pubitemid 351566346)
52. Y. Yang, E. Moir, G. Kontopidis, P. Taylor, M.A. Wear, and K. Malone Structure-based discovery of a family of synthetic cyclophilin inhibitors showing a cyclosporin-A phenotype in CaenorhaBDIMtis elegans Biochem Biophys Res Commun 363 2007 1013 1019 (Pubitemid 47559156)
53. M&T Drug Interaction Database. Department of pharmaceutics. University of Washington [citado 5 Jun 2007]. Disponible en: www.druginteractioninfo.org
54. I. Ragueneau-Majlessi, X. Boulenc, C. Rauch, H. Hachad, and R.H. Levy Quantitative correlations among CYP3A sensitive substrates and inhibitors: literature analysis Curr Drug Metab 8 2007 810 814 (Pubitemid 350238910)
55. RAD-AR Council. Anti-hypertensive drug database [citado 25 May 2007]. Disponible en: www.rad-ar.ogr.jp
56. M. Yoshida, T. Matsumoto, T. Suzuki, S. Kitamura, and T. Mayama Effect of concomitant treatment with a CYP3A4 inhibitor and a calcium channel blocker Pharmacoepidemiol Drug Saf 17 2008 70 71
57. Side Effects software [citado 26 May 2007]. Disponible en: www.sidefx.com
58. G.N. Fox Drug interactions software programs J Fam Pract 33 1991 273 280
59. STICH [citado 27 May 2007]. Disponible en: www.stitch.embl.de
60. M. Kuhn, C. Von Mering, M. Campillos, L.J. Jensen, and P. Bork STITCH: interaction networks of chemicals and proteins Nucleic Acids Res 36 2008 D684 D688
61. The marine natural products database (MNPD) [citado 27 May 2007]. Disponible en: www.dmnp.chemnetbase.com
62. B. Liu, and J. Zhou SARS-CoV protease inhibitors design using virtual screening method from natural products libraries J Comput Chem 26 2005 484 490 (Pubitemid 40449460)
63. The traditional Chinese medicines database (TCMD) [citado 30 May 2007]. Disponible en: www.gfmer.ch
64. Veteran Health Administration (VHA) clinical database. Department of Veterans Affairs [citado 20 May 2007]. Disponible en: www.va.gov
65. D.D. French, and C.E. Margo Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or alpha-blockers Drug Saf 31 2008 241 247 (Pubitemid 351311579)
66. B. Janchawee, W. Wongpoowarak, T. Owatranporn, and V. Chongsuvivatwong Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand J Clin Pharm Ther 30 2005 13 20 (Pubitemid 41602088)
67. British National Formulary. BNF Group [citado 30 Jul 2007]. Disponible en: www.bnf.org
68. N. Tavassoli, A. Sommet, M. Lapeyre-Mestre, H. Bagheri, and J.L. Montrastruc Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal British National Formulary) Drug Saf 30 2007 1063 1071 (Pubitemid 350036604)
69. KS Mellbye, and C Berg Heavy consumers of drugs -seen from the viewpoint of the community pharmacist Tidsskr Nor Laegeforen 124 2004 3069 3071 (Pubitemid 40310945)
70. E.W. Nielsen, and K. Dybwik Drug interactions in an intensive care unit Tidsskr Nor Laegeforen 124 2004 2907 2908 (Pubitemid 40310973)
71. L. Guedon-Moreau, D. Ducrocq, M.F. Duc, Y. Quieureux, C. L'Hote, and J. Deligne Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999 Eur J Clin Pharmacol 59 2003 689 695 (Pubitemid 37494540)
72. L. Galatti, G. Mazzaglia, A. Greco, E. Sessa, C. Cricelli, and G.C. Schito Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice Pharmacoepidemiol Drug Saf 16 2007 422 428 (Pubitemid 46656864)
73. G. Trifiro, S. Corrao, M. Alacqua, S. Moretti, M. Tari, and A.P. Caputi Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drugrelated information sources Br J Clin Pharmacol 62 2006 582 590 (Pubitemid 44571580)
74. C.M. Hohl, J. Dankoff, A. Colacone, and M. Afilalo Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department Ann Emerg Med 38 2001 666 671 (Pubitemid 33131567)
75. F. Vroom, E.N. Van Roon, P.B. Van den Berg, J.R. Brouwers, and L.T. De Jong-van den Berg Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy -a descriptive study Pharmacoepidemiol Drug Saf 17 2008 52 61 (Pubitemid 351166618)
76. Walgreens.com [citado 28 May 2007]. Disponible en: www.walgreens.com
77. A2Z Drugs [citado 3 Jun 2007]. Disponible en: www.az2drugs.com
78. K.A. Clauson, M.J. Seamon, A.S. Clauson, and T.B. Van Evaluation of drug information databases for personal digital assistants Am J Health Syst Pharm 61 2004 1015 1024 (Pubitemid 39481492)
79. Clinical Pharmacology on hand [citado 2 Jun 2007]. Disponible en: www.cponhand.gsm.com
80. PDR. Drug Interaction [citado 25 May 2007]. Disponible en: www.pdr.net
81. Tarascon Pocket Pharmacopoeia [citado 25 May 2007]. Disponible en: www.tarascon.com
82. Triple Prescribing Guide [citado 3 Jun 2007]. Disponible en: www.pharmscope.com